Pattern of use, safety and tolerability of the diagnostic agent NeuraCeqTM in European clinical practice: A cross-sectional, retrospective, non-interventional post-authorisation safety study (PASS) (FBB-01_03_13)

First published 16/06/2016

Last updated 10/03/2021

EU PAS number:

EUPAS13366

Study

Finalised

Download as PDF

Documents

Study protocol

No information provided.

Study results

No information provided.

Study report

No information provided.

ENCePP Seal

The use of the ENCePP Seal has been discontinued since February 2025. The ENCePP Seal fields are retained in the display mode for transparency but are no longer maintained.

No information provided.

Pattern of use, safety and tolerability of the diagnostic agent NeuraCeqTM in European clinical practice: A cross-sectional, retrospective, non-interventional post-authorisation safety study (PASS) (FBB-01_03_13)

Secondary tabs

Share this page